NEWARK, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at the 2013 Regen Med Investor Day to be held on Wednesday, April 17, 2013, at the Harmonie Club, 4 East 60 th Street, New York, NY. Mr. McGlynn is scheduled to make his presentation at 4:00 pm EDT. In addition, Stephen Huhn, MD, FACS, FAAP, Vice President and Head of the CNS Program at StemCells, Inc., will participate in an expert panel discussion on "Therapeutics for a Broad Range of CNS Diseases," which is scheduled to begin at 11:05 am EDT. All the day's events, including Mr. McGlynn's presentation and Dr. Huhn's panel discussion, will be webcast live and available at http://alliancerm.org/rmdaywebcast .
The 2013 Regen Med Investor Day, which is organized by the Alliance for Regenerative Medicine (ARM) and co-hosted by leading financial firms Burrill & Company, Maxim Group and Piper Jaffray, is intended to provide institutional, strategic and venture investors unique insight into the investment thesis for regenerative medicine-based therapeutics and tools. The 2013 Regen Med Investor Day will begin with keynote talks by Jeff Jonas, President of Shire Regenerative Medicine and Kieran Murphy, President and CEO, GE Healthcare Life Sciences. These will be followed by focused discussions among key opinion leaders, top investment analysts and senior company executives on three of the industry's more prominent target indications, including disorders of the central nervous system (CNS). Company presentations, showcasing 16 leading, publicly traded small- and mid-cap companies in the field, will be in the afternoon.
Attendance at this event is for credentialed investors and members of the media only. If you are interested in attending, please contact Laura Parsons at firstname.lastname@example.org. More information is available at http://alliancerm.org/event/regen-med-investor-day .A replay of the webcast will be available on ARM's website shortly after the event.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV